19.23
price down icon1.18%   -0.23
pre-market  Vorhandelsmarkt:  19.37   0.14   +0.73%
loading
Schlusskurs vom Vortag:
$19.46
Offen:
$19.5
24-Stunden-Volumen:
2.10M
Relative Volume:
0.54
Marktkapitalisierung:
$14.28B
Einnahmen:
$220.00K
Nettoeinkommen (Verlust:
$-746.08M
KGV:
-19.09
EPS:
-1.0074
Netto-Cashflow:
$-211.81M
1W Leistung:
+2.61%
1M Leistung:
-8.21%
6M Leistung:
-20.24%
1J Leistung:
-13.53%
1-Tages-Spanne:
Value
$19.03
$19.76
1-Wochen-Bereich:
Value
$18.46
$20.51
52-Wochen-Spanne:
Value
$15.55
$36.91

Summit Therapeutics Inc Stock (SMMT) Company Profile

Name
Firmenname
Summit Therapeutics Inc
Name
Telefon
305-203-2034
Name
Adresse
601 BRICKELL KEY DRIVE, MIAMI
Name
Mitarbeiter
159
Name
Twitter
@summitplc
Name
Nächster Verdiensttermin
2025-10-20
Name
Neueste SEC-Einreichungen
Name
SMMT's Discussions on Twitter

Vergleichen Sie SMMT mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
SMMT
Summit Therapeutics Inc
19.23 14.49B 220.00K -746.08M -211.81M -1.0074
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
422.39 107.73B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
654.48 62.04B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
475.91 62.73B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
ARGX
Argen X Se Adr
836.39 51.09B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
165.29 34.67B 398.11M -1.03B -868.57M -5.7032

Summit Therapeutics Inc Stock (SMMT) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-09-17 Eingeleitet Barclays Underweight
2025-09-04 Eingeleitet Guggenheim Buy
2025-08-19 Eingeleitet Piper Sandler Neutral
2025-07-01 Eingeleitet UBS Buy
2025-06-11 Eingeleitet Leerink Partners Underperform
2025-03-26 Hochstufung Citigroup Neutral → Buy
2025-03-21 Eingeleitet Cantor Fitzgerald Overweight
2025-03-12 Eingeleitet Evercore ISI Outperform
2025-02-28 Eingeleitet Goldman Buy
2025-01-08 Eingeleitet Truist Buy
2024-12-11 Eingeleitet Wells Fargo Overweight
2024-12-06 Eingeleitet Jefferies Buy
2024-11-04 Eingeleitet JMP Securities Mkt Outperform
2024-09-27 Herabstufung Citigroup Buy → Neutral
2024-08-12 Eingeleitet H.C. Wainwright Buy
2024-05-07 Eingeleitet Citigroup Buy
2024-03-26 Eingeleitet Stifel Buy
2018-06-28 Herabstufung Janney Buy → Neutral
2018-05-02 Eingeleitet Janney Buy
2018-04-12 Bestätigt Needham Buy
2018-02-13 Eingeleitet BTIG Research Buy
2018-01-04 Eingeleitet SunTrust Buy
2017-12-01 Fortgesetzt H.C. Wainwright Buy
2016-11-16 Bestätigt RBC Capital Mkts Outperform
2016-10-05 Bestätigt Needham Buy
2016-09-16 Eingeleitet H.C. Wainwright Buy
2015-03-30 Eingeleitet Needham Buy
2015-03-30 Eingeleitet Oppenheimer Outperform
Alle ansehen

Summit Therapeutics Inc Aktie (SMMT) Neueste Nachrichten

pulisher
04:26 AM

Is Summit Therapeutics Inc. showing signs of accumulationJuly 2025 Sentiment & Community Trade Idea Sharing - newser.com

04:26 AM
pulisher
01:52 AM

Is Summit Therapeutics Inc. stock reversal real or fake2025 Market WrapUp & Scalable Portfolio Growth Ideas - newser.com

01:52 AM
pulisher
Oct 28, 2025

Applying sector rotation models to Summit Therapeutics Inc.Portfolio Gains Report & Proven Capital Preservation Methods - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Co-CEO & Executive Chairman of Summit Therapeutics Picks Up 2.5% More Stock - simplywall.st

Oct 28, 2025
pulisher
Oct 28, 2025

Co-CEO & Executive Chairman of Summit Therapeutics Robert Duggan Buys 2.5% More Shares - Yahoo Finance

Oct 28, 2025
pulisher
Oct 28, 2025

Insider Spends US$262m Buying More Shares In Summit Therapeutics - 富途牛牛

Oct 28, 2025
pulisher
Oct 28, 2025

What institutional flow reveals about Summit Therapeutics Inc.2025 Bull vs Bear & Risk Adjusted Buy and Sell Alerts - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Analyzing Summit Therapeutics Inc. with risk reward ratio charts2025 Performance Recap & Weekly High Momentum Picks - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

What margin trends mean for Summit Therapeutics Inc. stock2025 Top Decliners & Fast Exit/Entry Strategy Plans - Fundação Cultural do Pará

Oct 28, 2025
pulisher
Oct 27, 2025

Can Summit Therapeutics Inc. hit a new high this month2025 Winners & Losers & Low Risk Entry Point Guides - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Should you hold or exit Summit Therapeutics Inc. nowRecession Risk & AI Based Trade Execution Alerts - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Summit Therapeutics proves InvestingPro’s Fair Value accuracy with 40% return By Investing.com - Investing.com South Africa

Oct 27, 2025
pulisher
Oct 27, 2025

1 Monster Stock in the Making to Buy and Hold - Yahoo Finance

Oct 27, 2025
pulisher
Oct 27, 2025

News impact scoring models applied to Summit Therapeutics Inc.Fed Meeting & Risk Managed Investment Strategies - newser.com

Oct 27, 2025

Finanzdaten der Summit Therapeutics Inc-Aktie (SMMT)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$36.41
price down icon 2.28%
$91.65
price down icon 1.54%
$29.13
price up icon 0.34%
$105.03
price down icon 0.96%
biotechnology ONC
$316.85
price up icon 0.45%
$165.29
price up icon 0.77%
Kapitalisierung:     |  Volumen (24h):